NCT02232113View on ClinicalTrials.gov

Frequent Dosing of CERA Improves Nutrition and Inflammation in Hemodialysis Patients

PHASE4CompletedINTERVENTIONAL
Enrollment

67

Participants

Timeline

Start Date

February 29, 2012

Primary Completion Date

January 31, 2013

Study Completion Date

January 31, 2013

Conditions
AnemiaInflammationMalnutrition
Interventions
DRUG

CERA

changing frequency of administration from once to twice monthly under a fixed total monthly dose of CERA

Trial Locations (1)

112

Taipei Veterans General Hospital, Taipei

All Listed Sponsors
collaborator

Taipei City Hospital

OTHER_GOV

lead

Taipei Veterans General Hospital, Taiwan

OTHER_GOV

NCT02232113 - Frequent Dosing of CERA Improves Nutrition and Inflammation in Hemodialysis Patients | Biotech Hunter | Biotech Hunter